TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Daraxonrasib Doubles Survival in Advanced Pancreatic Cancer Patients
    May 7, 2026
  • Atomic-level snapshots reveal how a key copper enzyme powers nature’s chemistry
    May 7, 2026
  • Stem cell model of human embryo produces yolk sac without hypoblasts or genetic trickery
    May 6, 2026
  • New Insight into the Brain Regions Used When Learning to Speak May Inform Rehab After Stroke or Brain Injury
    May 3, 2026
  • The Type of Fat—Not the Amount—Fuels Pancreatic Cancer
    May 2, 2026
More news.
© 2017 - 2026 Innovita Research | Privacy policy